119 related articles for article (PubMed ID: 37245852)
1. Neuroprotection in Cerebral Cortex Induced by the Pregnancy Hormone Estriol.
Meyer CE; Smith AW; Padilla-Requerey AA; Farkhondeh V; Itoh N; Itoh Y; Gao JL; Herbig PD; Nguyen Q; Ngo KH; Oberoi MR; Siddarth P; Voskuhl RR; MacKenzie-Graham A
Lab Invest; 2023 Aug; 103(8):100189. PubMed ID: 37245852
[TBL] [Abstract][Full Text] [Related]
2. Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease.
Ziehn MO; Avedisian AA; Dervin SM; O'Dell TJ; Voskuhl RR
Lab Invest; 2012 Aug; 92(8):1234-45. PubMed ID: 22525427
[TBL] [Abstract][Full Text] [Related]
3. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis.
Kim S; Liva SM; Dalal MA; Verity MA; Voskuhl RR
Neurology; 1999 Apr; 52(6):1230-8. PubMed ID: 10214749
[TBL] [Abstract][Full Text] [Related]
4. Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis.
Itoh N; Kim R; Peng M; DiFilippo E; Johnsonbaugh H; MacKenzie-Graham A; Voskuhl RR
J Neuroimmunol; 2017 Mar; 304():63-71. PubMed ID: 27771018
[TBL] [Abstract][Full Text] [Related]
5. Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
Palaszynski KM; Liu H; Loo KK; Voskuhl RR
J Neuroimmunol; 2004 Apr; 149(1-2):84-9. PubMed ID: 15020068
[TBL] [Abstract][Full Text] [Related]
6. Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).
Gold SM; Sasidhar MV; Morales LB; Du S; Sicotte NL; Tiwari-Woodruff SK; Voskuhl RR
Lab Invest; 2009 Oct; 89(10):1076-83. PubMed ID: 19668239
[TBL] [Abstract][Full Text] [Related]
7. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
[TBL] [Abstract][Full Text] [Related]
8. Diosgenin ameliorates cellular and molecular changes in multiple sclerosis in C57BL/6 mice.
Zeinali H; Baluchnejadmojarad T; Roghani M
Mult Scler Relat Disord; 2021 Oct; 55():103211. PubMed ID: 34425463
[TBL] [Abstract][Full Text] [Related]
9. Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis.
MacKenzie-Graham AJ; Rinek GA; Avedisian A; Morales LB; Umeda E; Boulat B; Jacobs RE; Toga AW; Voskuhl RR
J Neurosci Res; 2012 Jul; 90(7):1310-23. PubMed ID: 22411609
[TBL] [Abstract][Full Text] [Related]
10. Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis.
Voskuhl RR; Itoh N; Tassoni A; Matsukawa MA; Ren E; Tse V; Jang E; Suen TT; Itoh Y
Proc Natl Acad Sci U S A; 2019 May; 116(20):10130-10139. PubMed ID: 31040210
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.
Wen J; Ariyannur PS; Ribeiro R; Tanaka M; Moffett JR; Kirmani BF; Namboodiri AM; Zhang Y
J Neuroimmune Pharmacol; 2016 Dec; 11(4):763-773. PubMed ID: 27562847
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice.
Tiwari-Woodruff S; Voskuhl RR
J Neurol Sci; 2009 Nov; 286(1-2):81-5. PubMed ID: 19442988
[TBL] [Abstract][Full Text] [Related]
13. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
Kumar S; Patel R; Moore S; Crawford DK; Suwanna N; Mangiardi M; Tiwari-Woodruff SK
Neurobiol Dis; 2013 Aug; 56():131-44. PubMed ID: 23603111
[TBL] [Abstract][Full Text] [Related]
15. Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3β pathway.
Sadek MA; Kandil EA; El Sayed NS; Sayed HM; Rabie MA
Int Immunopharmacol; 2023 Feb; 115():109647. PubMed ID: 36584570
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration.
Spence RD; Voskuhl RR
Front Neuroendocrinol; 2012 Jan; 33(1):105-15. PubMed ID: 22209870
[TBL] [Abstract][Full Text] [Related]
17. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.
Tremolanti C; Cavallini C; Meyer L; Klein C; Da Pozzo E; Costa B; Germelli L; Taliani S; Patte-Mensah C; Mensah-Nyagan AG
Mol Neurobiol; 2022 Mar; 59(3):1744-1765. PubMed ID: 35018577
[TBL] [Abstract][Full Text] [Related]
18. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
[TBL] [Abstract][Full Text] [Related]
19. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains.
Bebo BF; Fyfe-Johnson A; Adlard K; Beam AG; Vandenbark AA; Offner H
J Immunol; 2001 Feb; 166(3):2080-9. PubMed ID: 11160259
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system targeted autoimmunity causes regional atrophy: a 9.4T MRI study of the EAE mouse model of Multiple Sclerosis.
Hamilton AM; Forkert ND; Yang R; Wu Y; Rogers JA; Yong VW; Dunn JF
Sci Rep; 2019 Jun; 9(1):8488. PubMed ID: 31186441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
